GlassScriptPhysician profile
Jed A Gorden
NPI 1275630147
$235,788.18
in general payments reported to CMS, 2019-2025
15 companies · $7,662 in 2025
The $7,662 reported for 2025 was more than what 91% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $44K · 2020: $34K · 2021: $34K · 2022: $42K · 2023: $41K · 2024: $33K · 2025: $7,662.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $54K · Consulting Fee: $13K · Travel and Lodging: $11K · Food and Beverage: $3,136 · Education: $17.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $54,240.00 |
| Consulting Fee | $13,249.25 |
| Travel and Lodging | $10,910.18 |
| Food and Beverage | $3,135.87 |
| Education | $17.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $205,878.67 | 2019-2025 | Imfinzi, Tagrisso, Calquence |
| Daiichi Sankyo INC. | $16,940.91 | 2021-2024 | Enhertu |
| Verathon INC. | $4,525.00 | 2019-2023 | Bronchoscope |
| Pinnacle Biologics, INC | $2,749.38 | 2019-2024 | Photofrin |
| Astrazeneca Uk Limited | $1,974.00 | 2021-2022 | |
| Pfizer INC. | $1,480.00 | 2021 | |
| Ethicon INC. | $753.86 | 2021-2025 | Monarch Platform |
| Siemens Medical Solutions USA, INC. | $603.55 | 2023 | Somatom Go.Top |
| Medtronic, INC. | $263.33 | 2023-2024 | Endoflip, Illumisite |
| Atricure, INC. | $256.33 | 2022-2023 | |
| Boston Scientific Corporation | $169.48 | 2019-2021 | |
| Intuitive Surgical, INC. | $125.03 | 2022 | |
| Fujifilm Healthcare Americas Corporation | $34.78 | 2023 | Fujifilm |
| Insmed, INC. | $17.38 | 2025 | Brinsupri |
| Covidien LP | $16.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jed Gorden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.